Role of the RNA-binding protein La in cancer pathobiology

References

• Corley M, Burns MC, Yeo GW. How RNA-binding proteins interact with RNA: molecules and mechanisms. Mol Cell. 2020;78:9–29.
   PubMed Web of Science ®Google Scholar
• Hentze MW, Castello A, Schwarzl T, et al. A brave new world of RNA-binding proteins. Nat Rev Mol Cell Biol. 2018;19:327–341.
   PubMed Web of Science ®Google Scholar
• Kechavarzi B, Janga SC. Dissecting the expression landscape of RNA-binding proteins in human cancers. Genome Biol. 2014;15:R14.
   PubMed Web of Science ®Google Scholar
• Galante PA, Sandhu D, de Sousa Abreu R, et al. A comprehensive in silico expression analysis of RNA binding proteins in normal and tumor tissue: identification of potential players in tumor formation. RNA Biol. 2009;6:426–433.
   PubMed Web of Science ®Google Scholar
• Gerstberger S, Hafner M, Ascano M, et al. Evolutionary conservation and expression of human RNA-binding proteins and their role in human genetic disease. Ad Exp Med Biol. 2014;825:1–55.
   PubMed Web of Science ®Google Scholar
• Mattioli M, Reichlin M. Heterogeneity of RNA protein antigens reactive with sera of patients with systemic lupus erythematosus. Description of a cytoplasmic nonribosomal antigen. Arthritis Rheum. 1974;17:421–429.
   PubMed Web of Science ®Google Scholar
• Alspaugh MA, Talal N, Tan EM. Differentiation and characterization of autoantibodies and their antigens in Sjogren’s syndrome. Arthritis Rheum. 1976;19:216–222.
   PubMed Web of Science ®Google Scholar
• Wolin SL, Cedervall T. The la protein. Annu Rev Biochem. 2002;71:375–403.
   PubMed Web of Science ®Google Scholar
• Bousquet-Antonelli C, Deragon JM. A comprehensive analysis of the La-motif protein superfamily. RNA. 2009;15:750–764.
   PubMed Web of Science ®Google Scholar
• Maraia RJ, Mattijssen S, Cruz-Gallardo I, et al. The La and related RNA-binding proteins (LARPs): structures, functions, and evolving perspectives. Wiley Interdiscip Rev RNA. 2017;8(6).
   Web of Science ®Google Scholar
• Bayfield MA, Vinayak J, Kerkhofs K, et al. La proteins couple use of sequence-specific and non-specific binding modes to engage RNA substrates. RNA Biol. 2019;1–10. DOI:10.1080/15476286.2019.1582955
   PubMed Web of Science ®Google Scholar
• Kenan DJ, Keene JD. La gets its wings. Nat Struct Mol Biol. 2004;11:303–305.
   PubMed Web of Science ®Google Scholar
• Chambers JC, Keene JD. Isolation and analysis of cDNA clones expressing human lupus La antigen. Proc Natl Acad Sci U S A. 1985;82:2115–2119.
   PubMed Web of Science ®Google Scholar
• Chambers JC, Kenan D, Martin BJ, et al. Genomic structure and amino acid sequence domains of the human La autoantigen. J Biol Chem. 1988;263:18043–18051.
   PubMed Web of Science ®Google Scholar
• Bayfield MA, Yang R, Maraia RJ. Conserved and divergent features of the structure and function of La and La-related proteins (LARPs). Biochim Biophys Acta. 1799(5–6);365–378.
   Google Scholar
• Dock Bregeon AC, Lewis KA, Conte MR. The La-related proteins: structures and interactions of a versatile superfamily of RNA binding proteins. RNA Biol. 2019;1–16. DOI:10.1080/15476286.2019.1695712
   PubMed Web of Science ®Google Scholar
• Dong G, Chakshusmathi G, Wolin SL, et al. Structure of the La motif: a winged helix domain mediates RNA binding via a conserved aromatic patch. Embo J. 2004;23:1000–1007.
   PubMed Web of Science ®Google Scholar
• Teplova M, Yuan YR, Phan AT, et al. Structural basis for recognition and sequestration of UUU(OH) 3ʹ temini of nascent RNA polymerase III transcripts by La, a rheumatic disease autoantigen. Mol Cell. 2006;21:75–85.
   PubMed Web of Science ®Google Scholar
• Stavraka C, Blagden S. The La-related proteins, a family with connections to cancer. Biomolecules. 2015;5:2701–2722.
   PubMed Web of Science ®Google Scholar
• Koso H, Yi H, Sheridan P, et al. Identification of RNA-binding protein LARP4B as a tumor suppressor in glioma. Cancer Res. 2016;76:2254–2264.
   PubMed Web of Science ®Google Scholar
• Ye L, Lin ST, Mi YS, et al. Overexpression of LARP1 predicts poor prognosis of colorectal cancer and is expected to be a potential therapeutic target. Tumour Biol. 2016;37:14585–14594.
   PubMedGoogle Scholar
• Seetharaman S, Flemyng E, Shen J, et al. The RNA-binding protein LARP4 regulates cancer cell migration and invasion. Cytoskeleton (Hoboken). 2016;73:680–690.
   PubMed Web of Science ®Google Scholar
• Burrows C, Abd Latip N, Lam SJ, et al. The RNA binding protein Larp1 regulates cell division, apoptosis and cell migration. Nucleic Acids Res. 2010;38:5542–5553.
   PubMed Web of Science ®Google Scholar
• Hopkins TG, Mura M, Al-Ashtal HA, et al. The RNA-binding protein LARP1 is a post-transcriptional regulator of survival and tumorigenesis in ovarian cancer. Nucleic Acids Res. 2016;44:1227–1246.
   PubMed Web of Science ®Google Scholar
• Mura M, Hopkins TG, Michael T, et al. LARP1 post-transcriptionally regulates mTOR and contributes to cancer progression. Oncogene. 2015;34:5025–5036.
   PubMed Web of Science ®Google Scholar
• Ji X, Lu H, Zhou Q, et al. LARP7 suppresses P-TEFb activity to inhibit breast cancer progression and metastasis. eLife. 2014;3:e02907.
   PubMed Web of Science ®Google Scholar
• Jacks A, Babon J, Kelly G, et al. Structure of the C-terminal domain of human La protein reveals a novel RNA recognition motif coupled to a helical nuclear retention element. Structure. 2003;11:833–843.
   PubMed Web of Science ®Google Scholar
• Horke S, Reumann K, Schulze C, et al. The La motif and the RNA recognition motifs of human La autoantigen contribute individually to RNA recognition and subcellular localization. J Biol Chem. 2004;279:50302–50309.
   PubMed Web of Science ®Google Scholar
• Kuehnert J, Sommer G, Zierk AW, et al. Novel RNA chaperone domain of RNA-binding protein La is regulated by AKT phosphorylation. Nucleic Acids Res. 2015;43:581–594.
   PubMed Web of Science ®Google Scholar
• Martino L, Pennell S, Kelly G, et al. Analysis of the interaction with the hepatitis C virus mRNA reveals an alternative mode of RNA recognition by the human La protein. Nucleic Acids Res. 2012;40:1381–1394.
   PubMed Web of Science ®Google Scholar
• Simons FH, Broers FJ, Van Venrooij WJ, et al. Characterization of cis-acting signals for nuclear import and retention of the La (SS-B) autoantigen. Exp Cell Res. 1996;224:224–236.
   PubMed Web of Science ®Google Scholar
• Horke S, Reumann K, Schweizer M, et al. Nuclear trafficking of La protein depends on a newly identified nucleolar localization signal and the ability to bind RNA. J Biol Chem. 2004;279:26563–26570. Epub 2004 Apr 1.
   PubMed Web of Science ®Google Scholar
• Intine RV, Dundr M, Vassilev A, et al. Nonphosphorylated human La antigen interacts with nucleolin at nucleolar sites involved in rRNA biogenesis. Mol Cell Biol. 2004;24:10894–10904.
   PubMed Web of Science ®Google Scholar
• Bayfield MA, Kaiser TE, Intine RV, et al. Conservation of a masked nuclear export activity of La proteins and its effects on tRNA maturation. Mol Cell Biol. 2007;27:3303–3312.
   PubMed Web of Science ®Google Scholar
• Intine RV, Dundr M, Misteli T, et al. Aberrant nuclear trafficking of La protein leads to disordered processing of associated precursor tRNAs. Mol Cell. 2002;9:1113–1123.
   PubMed Web of Science ®Google Scholar
• Intine RV, Tenenbaum SA, Sakulich AL, et al. Differential phosphorylation and subcellular localization of La RNPs associated with precursor tRNAs and translation-related mRNAs. Mol Cell. 2003;12:1301–1307.
   PubMed Web of Science ®Google Scholar
• Brenet F, Socci ND, Sonenberg N, Holland EC. Akt phosphorylation of La regulates specific mRNA translation in glial progenitors. Oncogene. 2009;28:128–139.
   PubMed Web of Science ®Google Scholar
• Bachmann M, Pfeifer K, Schroder HC, et al. The La antigen shuttles between the nucleus and the cytoplasm in CV-1 cells. Mol Cell Biochem. 1989;85:103–114.
   PubMed Web of Science ®Google Scholar
• Petz M, Them NC, Huber H, et al. PDGF enhances IRES-mediated translation of Laminin B1 by cytoplasmic accumulation of La during epithelial to mesenchymal transition. Nucleic Acids Res. 2012;40:9738–9749.
   PubMed Web of Science ®Google Scholar
• Bachmann M, Chang S, Slor H, et al. Shuttling of the autoantigen La between nucleus and cell surface after UV irradiation of human keratinocytes. Exp Cell Res. 1990;191:171–180.
   PubMed Web of Science ®Google Scholar
• Fok V, Friend K, Steitz JA. Epstein-Barr virus noncoding RNAs are confined to the nucleus, whereas their partner, the human La protein, undergoes nucleocytoplasmic shuttling. J Cell Biol. 2006;173:319–325.
   PubMed Web of Science ®Google Scholar
• Craig A, Svitkin Y, Lee H, et al. The La autoantigen contains a dimerization domain that is essential for enhancing translation. Mol Cell Biol. 1997;17:163–169.
   PubMed Web of Science ®Google Scholar
• Trotta R, Vignudelli T, Candini O, et al. BCR/ABL activates mdm2 mRNA translation via the La antigen. Cancer Cell. 2003;3:145–160.
   PubMed Web of Science ®Google Scholar
• Costa-Mattioli M, Svitkin Y, Sonenberg N. La autoantigen is necessary for optimal function of the poliovirus and hepatitis C virus internal ribosome entry site in vivo and in vitro. Mol Cell Biol. 2004;24:6861–6870.
   PubMed Web of Science ®Google Scholar
• Heise T, Kota V, Brock A, et al. The La protein counteracts cisplatin-induced cell death by stimulating protein synthesis of anti-apoptotic factor Bcl2. Oncotarget. 2016;7:29664–29676.
   PubMedGoogle Scholar
• Bachmann M, Pfeifer K, Schroder HC, et al. Characterization of the autoantigen La as a nucleic acid-dependent ATPase/dATPase with melting properties. Cell. 1990;60:85–93.
   PubMed Web of Science ®Google Scholar
• Huhn P, Pruijn GJ, van Venrooij WJ, et al. Characterization of the autoantigen La (SS-B) as a dsRNA unwinding enzyme. Nucleic Acids Res. 1997;25:410–416.
   PubMed Web of Science ®Google Scholar
• Chakshusmathi G, Kim SD, Rubinson DA, et al. A La protein requirement for efficient pre-tRNA folding. Embo J. 2003;22:6562–6572.
   PubMed Web of Science ®Google Scholar
• Wolin SL, Wurtmann EJ. Molecular chaperones and quality control in noncoding RNA biogenesis. Cold Spring Harb Symp Quant Biol. 2006;71:505–511.
   PubMedGoogle Scholar
• Xiao Q, Sharp TV, Jeffrey IW, et al. The La antigen inhibits the activation of the interferon-inducible protein kinase PKR by sequestering and unwinding double-stranded RNA. Nucleic Acids Res. 1994;22:2512–2518.
   PubMed Web of Science ®Google Scholar
• Belisova A, Semrad K, Mayer O, et al. RNA chaperone activity of protein components of human Ro RNPs. RNA. 2005;11:1084–1094.
   PubMed Web of Science ®Google Scholar
• Hussain RH, Zawawi M, Bayfield MA. Conservation of RNA chaperone activity of the human La-related proteins 4, 6 and 7. Nucleic Acids Res. 2013;41:8715–8725.
   PubMed Web of Science ®Google Scholar
• Naeeni AR, Conte MR, Bayfield MA. RNA chaperone activity of human La protein is mediated by variant RNA recognition motif. J Biol Chem. 2012;287:5472–5482.
   PubMed Web of Science ®Google Scholar
• Kucera NJ, Hodsdon ME, Wolin SL. An intrinsically disordered C terminus allows the La protein to assist the biogenesis of diverse noncoding RNA precursors. Proc Natl Acad Sci U S A. 2011;108:1308–1313.
   PubMed Web of Science ®Google Scholar
• Alfano C, Sanfelice D, Babon J, et al. Structural analysis of cooperative RNA binding by the La motif and central RRM domain of human La protein. Nat Struct Mol Biol. 2004;11:323–329.
   PubMed Web of Science ®Google Scholar
• Pannone BK, Xue D, Wolin SL. A role for the yeast La protein in U6 snRNP assembly: evidence that the La protein is a molecular chaperone for RNA polymerase III transcripts. Embo J. 1998;17:7442–7453.
   PubMed Web of Science ®Google Scholar
• Yoo CJ, Wolin SL. The yeast La protein is required for the 3ʹ endonucleolytic cleavage that matures tRNA precursors. Cell. 1997;89:393–402.
   PubMed Web of Science ®Google Scholar
• Hasler D, Meister G. From tRNA to miRNA: RNA-folding contributes to correct entry into noncoding RNA pathways. FEBS Lett. 2016;590:2354–2363.
   PubMed Web of Science ®Google Scholar
• Hasler D, Lehmann G, Murakawa Y, et al. The lupus autoantigen La prevents mis-channeling of tRNA fragments into the human microRNA pathway. Mol Cell. 2016;63:110–124.
   PubMed Web of Science ®Google Scholar
• Liu Y, Tan H, Tian H, et al. Autoantigen La promotes efficient RNAi, antiviral response, and transposon silencing by facilitating multiple-turnover RISC catalysis. Mol Cell. 2011;44:502–508.
   PubMed Web of Science ®Google Scholar
• Liang C, Xiong K, Szulwach KE, et al. Sjogren syndrome antigen B (SSB)/La promotes global microRNA expression by binding microRNA precursors through stem-loop recognition. J Biol Chem. 2013;288:723–736.
   PubMed Web of Science ®Google Scholar
• Belsham GJ, Sonenberg N, Svitkin YV. The role of the La autoantigen in internal initiation. Curr Top Microbiol Immunol. 1995;203:85–98.
   PubMed Web of Science ®Google Scholar
• Svitkin YV, Meerovitch K, Lee HS, et al. Internal translation initiation on poliovirus RNA: further characterization of La function in poliovirus translation in vitro. J Virol. 1994;68:1544–1550.
   PubMed Web of Science ®Google Scholar
• Svitkin YV, Pause A, Sonenberg N. La autoantigen alleviates translational repression by the 5ʹ leader sequence of the human immunodeficiency virus type 1 mRNA. J Virol. 1994;68:7001–7007.
   PubMed Web of Science ®Google Scholar
• Ali N, Pruijn GJ, Kenan DJ, et al. Human La antigen is required for the hepatitis C virus internal ribosome entry site-mediated translation. J Biol Chem. 2000;275:27531–27540.
   PubMed Web of Science ®Google Scholar
• Ali N, Siddiqui A. The La antigen binds 5ʹ noncoding region of the hepatitis C virus RNA in the context of the initiator AUG codon and stimulates internal ribosome entry site-mediated translation. Proc Natl Acad Sci U S A. 1997;94:2249–2254.
   PubMed Web of Science ®Google Scholar
• Pon JR, Marra MA. Driver and passenger mutations in cancer. Annu Rev Pathol. 2015;10:25–50.
   PubMed Web of Science ®Google Scholar
• Nagel R, Semenova EA, Berns A. Drugging the addict: non-oncogene addiction as a target for cancer therapy. EMBO Rep. 2016;17:1516–1531.
   PubMed Web of Science ®Google Scholar
• Solimini NL, Luo J, Elledge SJ. Non-oncogene addiction and the stress phenotype of cancer cells. Cell. 2007;130:986–988.
   PubMed Web of Science ®Google Scholar
• Rother RP, Thomas PS. La/SSB ribonucleoprotein levels increased in transformed cells. Clin Exp Immunol. 1991;83:369–374.
   PubMed Web of Science ®Google Scholar
• Al-Ejeh F, Darby JM, Brown MP. The La autoantigen is a malignancy-associated cell death target that is induced by DNA-damaging drugs. Clin Cancer Res. 2007;13:5509s–18s.
   PubMed Web of Science ®Google Scholar
• Sommer G, Dittmann J, Kuehnert J, et al. The RNA-binding protein La contributes to cell proliferation and CCND1 expression. Oncogene. 2011;30:434–444.
   PubMed Web of Science ®Google Scholar
• Sommer G, Rossa C, Chi AC, et al. Implication of RNA-binding protein La in proliferation, migration and invasion of lymph node-metastasized hypopharyngeal SCC cells. PLoS One. 2011;6:e25402.
   PubMed Web of Science ®Google Scholar
• Staudacher AH, Al-Ejeh F, Fraser CK, et al. The La antigen is over-expressed in lung cancer and is a selective dead cancer cell target for radioimmunotherapy using the La-specific antibody APOMAB(R). EJNMMI Res. 2014;4:2.
   PubMed Web of Science ®Google Scholar
• Nakatake M, Monte-Mor B, Debili N, et al. JAK2(V617F) negatively regulates p53 stabilization by enhancing MDM2 via La expression in myeloproliferative neoplasms. Oncogene. 2012;31:1323–1333.
   PubMed Web of Science ®Google Scholar
• Bachmann M, Hilker M, Grolz D, et al. Different La/SS-B mRNA isoforms are expressed in salivary gland tissue of patients with primary Sjogren’s syndrome. J Autoimmun. 1996;9:757–766.
   PubMed Web of Science ®Google Scholar
• Hilker M, Troster H, Grolz D, et al. The autoantigen La/SS-B: analysis of the expression of alternatively spliced La mRNA isoforms. Cell Tiss Res. 1996;284: 383–389.
   PubMed Web of Science ®Google Scholar
• Carter MS, Sarnow P. Distinct mRNAs that encode La autoantigen are differentially expressed and contain internal ribosome entry sites. J Biol Chem. 2000;275:28301–28307.
   PubMed Web of Science ®Google Scholar
• Huang M, Ida H, Arima K, et al. La autoantigen translocates to cytoplasm after cleavage during granzyme B-mediated cytotoxicity. Life Sci. 2007;81:1461–1466.
   PubMed Web of Science ®Google Scholar
• Romero V, Fellows E, Jenne DE, et al. Cleavage of La protein by granzyme H induces cytoplasmic translocation and interferes with La-mediated HCV-IRES translational activity. Cell Death Differ. 2009;16:340–348.
   PubMed Web of Science ®Google Scholar
• Heise T, Guidotti LG, Chisari FV. La autoantigen specifically recognizes a predicted stem-loop in hepatitis B virus RNA. J Virol. 1999;73:5767–5776.
   PubMed Web of Science ®Google Scholar
• Ayukawa K, Taniguchi S, Masumoto J, et al. La autoantigen is cleaved in the COOH terminus and loses the nuclear localization signal during apoptosis. J Biol Chem. 2000;275:34465–34470.
   PubMed Web of Science ®Google Scholar
• Pavon-Eternod M, Gomes S, Geslain R, et al. tRNA over-expression in breast cancer and functional consequences. Nucleic Acids Res. 2009;37:7268–7280.
   PubMed Web of Science ®Google Scholar
• Mahlab S, Tuller T, Linial M. Conservation of the relative tRNA composition in healthy and cancerous tissues. RNA. 2012;18:640–652.
   PubMed Web of Science ®Google Scholar
• Pavon-Eternod M, Gomes S, Rosner MR, et al. Overexpression of initiator methionine tRNA leads to global reprogramming of tRNA expression and increased proliferation in human epithelial cells. RNA. 2013;19:461–466.
   PubMed Web of Science ®Google Scholar
• Hinnebusch AG. Translational regulation of GCN4 and the general amino acid control of yeast. Annu Rev Microbiol. 2005;59:407–450.
   PubMed Web of Science ®Google Scholar
• Wan Makhtar WR, Browne G, Karountzos A, et al. Short stretches of rare codons regulate translation of the transcription factor ZEB2 in cancer cells. Oncogene. 2017;36:6640–6648.
   PubMed Web of Science ®Google Scholar
• Laplante M, Sabatini DM. Regulation of mTORC1 and its impact on gene expression at a glance. J Cell Sci. 2013;126:1713–1719.
   PubMed Web of Science ®Google Scholar
• Mattijssen S, Arimbasseri AG, Iben JR, et al. LARP4 mRNA codon-tRNA match contributes to LARP4 activity for ribosomal protein mRNA poly(A) tail length protection. eLife. 2017;12:6. pii: e28889.
   Google Scholar
• Sobala A, Hutvagner G. Transfer RNA-derived fragments: origins, processing, and functions. Wiley Interdiscip Rev RNA. 2011;2:853–862.
   PubMed Web of Science ®Google Scholar
• Grafanaki K, Anastasakis D, Kyriakopoulos G, et al. Translation regulation in skin cancer from a tRNA point of view. Epigenomics. 2019;11:215–245.
   PubMed Web of Science ®Google Scholar
• Soares AR, Santos M. Discovery and function of transfer RNA-derived fragments and their role in disease. Wiley Interdiscip Rev RNA. 2017;8(5).
   Web of Science ®Google Scholar
• Gaidamakov S, Maximova OA, Chon H, et al. Targeted deletion of the gene encoding the La autoantigen (Sjogren’s syndrome antigen B) in B cells or the frontal brain causes extensive tissue loss. Mol Cell Biol. 2014;34:123–131.
   PubMed Web of Science ®Google Scholar
• Blewett NH, Iben JR, Gaidamakov S, et al. La deletion from mouse brain alters pre-tRNA metabolism and accumulation of pre-5.8S rRNA, with neuron death and reactive astrocytosis. Mol Cell Biol. 2017;37(10):e00588-16.
   Web of Science ®Google Scholar
• Orioli A. tRNA biology in the omics era: stress signalling dynamics and cancer progression. Bioessays. 2017;39(3).
   Web of Science ®Google Scholar
• Grewal SS. Why should cancer biologists care about tRNAs? tRNA synthesis, mRNA translation and the control of growth. Biochim Biophys Acta. 2015;1849:898–907.
   PubMed Web of Science ®Google Scholar
• Francoeur AM, Chan EK, Garrels JI, et al. Characterization and purification of lupus antigen La, and RNA-binding protein. Mol Cell Biol. 1985;5:586–590.
   PubMed Web of Science ®Google Scholar
• Pfeifle J, Anderer FA, Franke M. Multiple phosphorylation of human SS-B/LA autoantigen and its effect on poly(U) and autoantibody binding. Biochim Biophys Acta. 1987;928:217–226.
   PubMedGoogle Scholar
• Bachmann M, Schroder HC, Wagner KG, et al. Purification and characterization of the Ro and La antigens. Modulation of their binding affinities to poly(U) by phosphorylation and the presence of ATP. Biol Chem Hoppe-Seyler. 1986;367:671–680.
   PubMed Web of Science ®Google Scholar
• Broekhuis CH, Neubauer G, van Der Heijden A, et al. Detailed analysis of the phosphorylation of the human La (SS-B) autoantigen. (De)phosphorylation does not affect its subcellular distribution. Biochemistry. 2000;39:3023–3033.
   PubMed Web of Science ®Google Scholar
• Fan H, Sakulich AL, Goodier JL, et al. Phosphorylation of the human La antigen on serine 366 can regulate recycling of RNA polymerase III transcription complexes. Cell. 1997;88:707–715.
   PubMed Web of Science ®Google Scholar
• Fan H, Goodier JL, Chamberlain JR, et al. 5ʹ processing of tRNA precursors can be modulated by the human La antigen phosphoprotein. Mol Cell Biol. 1998;18:3201–3211.
   PubMed Web of Science ®Google Scholar
• Intine RV, Sakulich AL, Koduru SB, et al. Control of transfer RNA maturation by phosphorylation of the human La antigen on serine 366. Mol Cell. 2000;6:339–348.
   PubMed Web of Science ®Google Scholar
• Schwartz EI, Intine RV, Maraia RJ. CK2 is responsible for phosphorylation of human La protein serine-366 and can modulate rpL37 5ʹ-terminal oligopyrimidine mRNA metabolism. Mol Cell Biol. 2004;24:9580–9591.
   PubMed Web of Science ®Google Scholar
• Filhol O, Giacosa S, Wallez Y, et al. Protein kinase CK2 in breast cancer: the CK2beta regulatory subunit takes center stage in epithelial plasticity. Cell Mol Life Sci. 2015;72:3305–3322.
   PubMed Web of Science ®Google Scholar
• Tang H, Massi D, Hemmings BA, et al. AKT-ions with a TWIST between EMT and MET. Oncotarget. 2016;7:62767–62777.
   PubMedGoogle Scholar
• Ruzzene M, Pinna LA. Addiction to protein kinase CK2: a common denominator of diverse cancer cells? Biochim Biophys Acta. 2010;1804:499–504.
   PubMed Web of Science ®Google Scholar
• Ruzzene M, Bertacchini J, Toker A, et al. Cross-talk between the CK2 and AKT signaling pathways in cancer. Adv Biol Regul. 2017;64:1–8.
   PubMedGoogle Scholar
• Vasudevan KM, Garraway LA. AKT signaling in physiology and disease. Curr Top Microbiol Immunol. 2010;347:105–133.
   PubMed Web of Science ®Google Scholar
• Aoki M, Fujishita T. Oncogenic Roles of the PI3K/AKT/mTOR Axis. Curr Top Microbiol Immunol. 2017;407:153–189.
   PubMed Web of Science ®Google Scholar
• van Niekerk EA, Willis DE, Chang JH, et al. Sumoylation in axons triggers retrograde transport of the RNA-binding protein La. Proc Natl Acad Sci U S A. 2007;104:12913–12918.
   PubMed Web of Science ®Google Scholar
• Kota V, Sommer G, Durette C, et al. SUMO-modification of the La protein facilitates binding to mRNA in vitro and in cells. PLoS One. 2016;11:e0156365.
   PubMedGoogle Scholar
• Kota V, Sommer G, Hazard ES, et al. SUMO modification of the RNA-binding protein La regulates cell proliferation and STAT3 protein stability. Mol Cell Biol. 2018;38(2):e00129-17.
   Web of Science ®Google Scholar
• Seeler JS, Dejean A. SUMO and the robustness of cancer. Nat Rev Cancer. 2017;17:184–197.
   PubMed Web of Science ®Google Scholar
• Eifler K, Vertegaal ACO. SUMOylation-mediated regulation of cell cycle progression and cancer. Trends Biochem Sci. 2015;40:779–793.
   PubMed Web of Science ®Google Scholar
• Watkins NJ, Lemm I, Ingelfinger D, et al. Assembly and maturation of the U3 snoRNP in the nucleoplasm in a large dynamic multiprotein complex. Mol Cell. 2004;16:789–798.
   PubMed Web of Science ®Google Scholar
• Valenta T, Hausmann G, Basler K. The many faces and functions of beta-catenin. Embo J. 2012;31:2714–2736.
   PubMed Web of Science ®Google Scholar
• Shang S, Hua F, Hu ZW. The regulation of beta-catenin activity and function in cancer: therapeutic opportunities. Oncotarget. 2017;8:33972–33989.
   PubMedGoogle Scholar
• Rosenthal EL, Matrisian LM. Matrix metalloproteases in head and neck cancer. Head Neck. 2006;28:639–648.
   PubMed Web of Science ®Google Scholar
• Holcik M, Korneluk RG. Functional characterization of the X-linked inhibitor of apoptosis (XIAP) internal ribosome entry site element: role of La autoantigen in XIAP translation. Mol Cell Biol. 2000;20:4648–4657.
   PubMed Web of Science ®Google Scholar
• Holcik M, Sonenberg N. TRANSLATIONAL CONTROL IN STRESS AND APOPTOSIS. Nat Rev Mol Cell Biol. 2005;6:318–327.
   PubMed Web of Science ®Google Scholar
• Perrotti D, Calabretta B. Translational regulation by the p210 BCR/ABL oncoprotein. Oncogene. 2004;23:3222–3229.
   PubMed Web of Science ®Google Scholar
• Fang G, Kim CN, Perkins CL, et al. CGP57148B (STI-571) induces differentiation and apoptosis and sensitizes Bcr-Abl-positive human leukemia cells to apoptosis due to antileukemic drugs. Blood. 2000;96:2246–2253.
   PubMed Web of Science ®Google Scholar
• Sherrill KW, Byrd MP, Van Eden ME, et al. BCL-2 translation is mediated via internal ribosome entry during cell stress. J Biol Chem. 2004;279:29066–29074.
   PubMed Web of Science ®Google Scholar
• Kampen KR, Sulima SO, Verbelen B, et al. The ribosomal RPL10 R98S mutation drives IRES-dependent BCL-2 translation in T-ALL. Leukemia. 2019;33:319–332.
   PubMed Web of Science ®Google Scholar
• Hinnebusch AG, Ivanov IP, Sonenberg N. Translational control by 5ʹ-untranslated regions of eukaryotic mRNAs. Science. 2016;352:1413–1416.
   PubMed Web of Science ®Google Scholar
• Gebauer F, Hentze MW. Molecular mechanisms of translational control. Nat Rev Mol Cell Biol. 2004;5:827–835.
   PubMed Web of Science ®Google Scholar
• Robichaud N, Sonenberg N. Translational control and the cancer cell response to stress. Curr Opin Cell Biol. 2017;45:102–109.
   PubMed Web of Science ®Google Scholar
• Godet AC, David F, Hantelys F, et al. IRES trans-acting factors, key actors of the stress response. Int J Mol Sci. 2019;20(4):924.
   Web of Science ®Google Scholar
• Kondrashov AV, Spriggs KA, Bushell M, et al. Co-ordinated regulation of translation following DNA damage. Cell Cycle. 2009;8:3067–3068.
   PubMed Web of Science ®Google Scholar
• Spriggs KA, Bushell M, Willis AE. Translational regulation of gene expression during conditions of cell stress. Mol Cell. 2010;40:228–237.
   PubMed Web of Science ®Google Scholar
• Spriggs KA, Stoneley M, Bushell M, et al. Re-programming of translation following cell stress allows IRES-mediated translation to predominate. Biol Cell. 2008;100:27–38.
   PubMed Web of Science ®Google Scholar
• Meerovitch K, Pelletier J, Sonenberg N. A cellular protein that binds to the 5ʹ-noncoding region of poliovirus RNA: implications for internal translation initiation. Genes Dev. 1989;3:1026–1034.
   PubMed Web of Science ®Google Scholar
• Pudi R, Srinivasan P, Das S. La protein binding at the GCAC site near the initiator AUG facilitates the ribosomal assembly on the hepatitis C virus RNA to influence internal ribosome entry site-mediated translation. J Biol Chem. 2004;279:29879–29888.
   PubMed Web of Science ®Google Scholar
• Svitkin YV, Ovchinnikov LP, Dreyfuss G, et al. General RNA binding proteins render translation cap dependent [published erratum appears in EMBO J 1997 Feb 17;16(4):896]. Embo J. 1996;15:7147–7155.
   PubMed Web of Science ®Google Scholar
• Koromilas AE. Roles of the translation initiation factor eIF2alpha serine 51 phosphorylation in cancer formation and treatment. Biochim Biophys Acta. 2015;1849:871–880.
   PubMed Web of Science ®Google Scholar
• Donnelly N, Gorman AM, Gupta S, et al. The eIF2alpha kinases: their structures and functions. Cell Mol Life Sci. 2013;70:3493–3511.
   PubMed Web of Science ®Google Scholar
• Wek RC. Role of eIF2alpha kinases in translational control and adaptation to cellular stress. Cold Spring Harbor Perspect Biol. 2018;10(7):a032870.
   Web of Science ®Google Scholar
• Garcia MA, Gil J, Ventoso I, et al. Impact of protein kinase PKR in cell biology: from antiviral to antiproliferative action. Microbiol Mol Biol Rev. 2006;70:1032–1060.
   PubMed Web of Science ®Google Scholar
• Sadler AJ, Williams BR. Structure and function of the protein kinase R. Curr Top Microbiol Immunol. 2007;316:253–292.
   PubMed Web of Science ®Google Scholar
• Clemens MJ, Elia A. The double-stranded RNA-dependent protein kinase PKR: structure and function. J Interferon Cytokine Res. 1997;17:503–524.
   PubMed Web of Science ®Google Scholar
• Boye E, Grallert B. eIF2alpha phosphorylation and the regulation of translation. Curr Genet. 2019;66(2):293–297.
   PubMed Web of Science ®Google Scholar
• James MC, Jeffrey IW, Pruijn GJ, et al. Translational control by the La antigen. Structure requirements for rescue of the double-stranded RNA-mediated inhibition of protein synthesis. Eur J Biochem. 1999;266:151–162.
   PubMedGoogle Scholar
• Youssef OA, Safran SA, Nakamura T, et al. Potential role for snoRNAs in PKR activation during metabolic stress. Proc Natl Acad Sci U S A. 2015;112:5023–5028.
   PubMed Web of Science ®Google Scholar
• Lee K, Kunkeaw N, Jeon SH, et al. Precursor miR-886, a novel noncoding RNA repressed in cancer, associates with PKR and modulates its activity. RNA. 2011;17:1076–1089.
   PubMed Web of Science ®Google Scholar
• Lee YS, Kunkeaw N, Lee YS. Protein kinase R and its cellular regulators in cancer: an active player or a surveillant? Wiley Interdiscip Rev RNA. 2020;11:e1558.
   PubMed Web of Science ®Google Scholar
• Chu WM, Ballard R, Carpick BW, et al. Potential Alu function: regulation of the activity of double-stranded RNA-activated kinase PKR. Mol Cell Biol. 1998;18:58–68.
   PubMed Web of Science ®Google Scholar
• Kim Y, Lee JH, Park JE, et al. PKR is activated by cellular dsRNAs during mitosis and acts as a mitotic regulator. Genes Dev. 2014;28:1310–1322.
   PubMed Web of Science ®Google Scholar
• Elbarbary RA, Li W, Tian B, et al. STAU1 binding 3ʹ UTR IRAlus complements nuclear retention to protect cells from PKR-mediated translational shutdown. Genes Dev. 2013;27:1495–1510.
   PubMed Web of Science ®Google Scholar
• Kufel J, Allmang C, Chanfreau G, et al. Precursors to the U3 small nucleolar RNA lack small nucleolar RNP proteins but are stabilized by La binding. Mol Cell Biol. 2000;20:5415–5424.
   PubMed Web of Science ®Google Scholar
• Maraia RJ, Kenan DJ, Keene JD. Eukaryotic transcription termination factor La mediates transcript release and facilitates reinitiation by RNA polymerase III. Mol Cell Biol. 1994;14:2147–2158.
   PubMed Web of Science ®Google Scholar
• Goodier JL, Fan H, Maraia RJ. A carboxy-terminal basic region controls RNA polymerase III transcription factor activity of human La protein. Mol Cell Biol. 1997;17:5823–5832.
   PubMed Web of Science ®Google Scholar
• Marchal JA, Lopez GJ, Peran M, et al. The impact of PKR activation: from neurodegeneration to cancer. Faseb J. 2014;28:1965–1974.
   PubMed Web of Science ®Google Scholar
• Kim SH, Gunnery S, Choe JK, et al. Neoplastic progression in melanoma and colon cancer is associated with increased expression and activity of the interferon-inducible protein kinase, PKR. Oncogene. 2002;21:8741–8748.
   PubMed Web of Science ®Google Scholar
• Peek R, Pruijn GJ, Van Venrooij WJ. Interaction of the La (SS-B) autoantigen with small ribosomal subunits. Eur J Biochem. 1996;236:649–655.
   PubMedGoogle Scholar
• Cardinali B, Carissimi C, Gravina P, et al. La protein is associated with terminal oligopyrimidine mRNAs in actively translating polysomes. J Biol Chem. 2003;278:35145–35151.
   PubMed Web of Science ®Google Scholar
• Vinayak J, Marrella SA, Hussain RH, et al. Human La binds mRNAs through contacts to the poly(A) tail. Nucleic Acids Res. 2018;46:4228–4240.
   PubMed Web of Science ®Google Scholar
• Lu WT, Wilczynska A, Smith E, et al. The diverse roles of the eIF4A family: you are the company you keep. Biochem Soc Trans. 2014;42:166–172.
   PubMed Web of Science ®Google Scholar
• Chu J, Pelletier J. Targeting the eIF4A RNA helicase as an anti-neoplastic approach. Biochim Biophys Acta. 2015;1849:781–791.
   PubMed Web of Science ®Google Scholar
• Pisareva VP, Pisarev AV, Komar AA, et al. Translation initiation on mammalian mRNAs with structured 5ʹUTRs requires DExH-box protein DHX29. Cell. 2008;135:1237–1250.
   PubMed Web of Science ®Google Scholar
• Pisareva VP, Pisarev AV. DHX29 and eIF3 cooperate in ribosomal scanning on structured mRNAs during translation initiation. RNA. 2016;22:1859–1870.
   PubMed Web of Science ®Google Scholar
• Dhote V, Sweeney TR, Kim N, et al. Roles of individual domains in the function of DHX29, an essential factor required for translation of structured mammalian mRNAs. Proc Natl Acad Sci U S A. 2012;109:E3150–9.
   PubMed Web of Science ®Google Scholar
• Kozak M. Compilation and analysis of sequences upstream from the translational start site in eukaryotic mRNAs. Nucleic Acids Res. 1984;12:857–872.
   PubMed Web of Science ®Google Scholar
• Kozak M. Point mutations define a sequence flanking the AUG initiator codon that modulates translation by eukaryotic ribosomes. Cell. 1986;44:283–292.
   PubMed Web of Science ®Google Scholar
• McBratney S, Sarnow P. Evidence for involvement of trans-acting factors in selection of the AUG start codon during eukaryotic translational initiation. Mol Cell Biol. 1996;16:3523–3534.
   PubMed Web of Science ®Google Scholar
• Meyuhas O, Kahan T. The race to decipher the top secrets of TOP mRNAs. Biochim Biophys Acta. 2015;1849:801–811.
   PubMed Web of Science ®Google Scholar
• Mandato E, Manni S, Zaffino F, et al. Targeting CK2-driven non-oncogene addiction in B-cell tumors. Oncogene. 2016;35:6045–6052.
   PubMed Web of Science ®Google Scholar
• Trembley JH, Wang G, Unger G, et al. Protein kinase CK2 in health and disease: CK2: a key player in cancer biology. Cell Mol Life Sci. 2009;66:1858–1867.
   PubMedGoogle Scholar
• Terenin IM, Smirnova VV, Andreev DE, et al. A researcher’s guide to the galaxy of IRESs. Cell Mol Life Sci. 2017;74:1431–1455.
   PubMed Web of Science ®Google Scholar
• Gilbert WV. Alternative ways to think about cellular internal ribosome entry. J Biol Chem. 2010;285:29033–29038.
   PubMed Web of Science ®Google Scholar
• Jackson RJ. The current status of vertebrate cellular mRNA IRESs. Cold Spring Harbor Perspect Biol. 2013;5(2):a011569.
   Web of Science ®Google Scholar
• Fabregat I, Caballero-Diaz D. Transforming growth factor-beta-induced cell plasticity in liver fibrosis and hepatocarcinogenesis. Front Oncol. 2018;8:357.
   PubMed Web of Science ®Google Scholar
• Mitra A, Mishra L, Li S. EMT, CTCs and CSCs in tumor relapse and drug-resistance. Oncotarget. 2015;6:10697–10711.
   PubMed Web of Science ®Google Scholar
• Papageorgis P. TGFbeta signaling in tumor initiation, epithelial-to-mesenchymal transition, and metastasis. J Oncol. 2015;2015:587193.
   PubMed Web of Science ®Google Scholar
• Saitoh M. Epithelial-mesenchymal transition is regulated at post-transcriptional levels by transforming growth factor-beta signaling during tumor progression. Cancer Sci. 2015;106:481–488.
   PubMed Web of Science ®Google Scholar
• Lamouille S, Xu J, Derynck R. Molecular mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell Biol. 2014;15:178–196.
   PubMed Web of Science ®Google Scholar
• Evdokimova V, Tognon CE, Sorensen PH. On translational regulation and EMT. Semin Cancer Biol. 2012;22:437–445.
   PubMed Web of Science ®Google Scholar
• Evdokimova V, Tognon C, Ng T, et al. Translational activation of snail1 and other developmentally regulated transcription factors by YB-1 promotes an epithelial-mesenchymal transition. Cancer Cell. 2009;15:402–415.
   PubMed Web of Science ®Google Scholar
• Chaudhury A, Hussey GS, Ray PS, et al. TGF-beta-mediated phosphorylation of hnRNP E1 induces EMT via transcript-selective translational induction of Dab2 and ILEI. Nat Cell Biol. 2010;12:286–293.
   PubMed Web of Science ®Google Scholar
• Hussey GS, Chaudhury A, Dawson AE, et al. Identification of an mRNP complex regulating tumorigenesis at the translational elongation step. Mol Cell. 2011;41:419–431.
   PubMed Web of Science ®Google Scholar
• Lim SO, Park SJ, Kim W, et al. Proteome analysis of hepatocellular carcinoma. Biochem Biophys Res Commun. 2002;291:1031–1037.
   PubMed Web of Science ®Google Scholar
• Givant-Horwitz V, Davidson B, Reich R. Laminin-induced signaling in tumor cells: the role of the M(r) 67,000 laminin receptor. Cancer Res. 2004;64:3572–3579.
   PubMed Web of Science ®Google Scholar
• Patarroyo M, Tryggvason K, Virtanen I. Laminin isoforms in tumor invasion, angiogenesis and metastasis. Semin Cancer Biol. 2002;12:197–207.
   PubMed Web of Science ®Google Scholar
• Petz M, Kozina D, Huber H, et al. The leader region of Laminin B1 mRNA confers cap-independent translation. Nucleic Acids Res. 2007;35:2473–2482.
   PubMed Web of Science ®Google Scholar
• Petz M, Them N, Huber H, et al. La enhances IRES-mediated translation of laminin B1 during malignant epithelial to mesenchymal transition. Nucleic Acids Res. 2012;40:290–302.
   PubMed Web of Science ®Google Scholar
• Gotzmann J, Fischer AN, Zojer M, et al. A crucial function of PDGF in TGF-beta-mediated cancer progression of hepatocytes. Oncogene. 2006;25:3170–3185.
   PubMed Web of Science ®Google Scholar
• Govaere O, Petz M, Wouters J, et al. The PDGFRalpha-laminin B1-keratin 19 cascade drives tumor progression at the invasive front of human hepatocellular carcinoma. Oncogene. 2017;36:6605–6616.
   PubMed Web of Science ®Google Scholar
• Kim JK, Diehl JA. Nuclear cyclin D1: an oncogenic driver in human cancer. J Cell Physiol. 2009;220:292–296.
   PubMed Web of Science ®Google Scholar
• Arnold A, Motokura T, Bloom T, et al. PRAD1 (cyclin D1): a parathyroid neoplasia gene on 11q13. Henry Ford Hosp Med J. 1992;40:177–180.
   PubMedGoogle Scholar
• Diehl JA. Cycling to cancer with cyclin D1. Cancer Biol Ther. 2002;1:226–231.
   PubMed Web of Science ®Google Scholar
• Ewen ME, Lamb J. The activities of cyclin D1 that drive tumorigenesis. Trends Mol Med. 2004;10:158–162.
   PubMed Web of Science ®Google Scholar
• Fu M, Wang C, Li Z, et al. Minireview: cyclin D1: normal and abnormal functions. Endocrinology. 2004;145:5439–5447.
   PubMed Web of Science ®Google Scholar
• Shi Y, Sharma A, Wu H, et al. Cyclin D1 and c-Myc internal ribosome entry site (IRES)-dependent translation is regulated by AKT activity and enhanced by rapamycin through a p38 MAPK and ERK-dependent pathway. J Biol Chem. 2005;280(12):10964-73.
   Google Scholar
• Frost P, Shi Y, Hoang B, et al. Regulation of D-cyclin translation inhibition in myeloma cells treated with mammalian target of rapamycin inhibitors: rationale for combined treatment with extracellular signal-regulated kinase inhibitors and rapamycin. Mol Cancer Ther. 2009;8:83–93.
   PubMed Web of Science ®Google Scholar
• Gera JF, Mellinghoff IK, Shi Y, et al. AKT activity determines sensitivity to mammalian target of rapamycin (mTOR) inhibitors by regulating cyclin D1 and c-myc expression. J Biol Chem. 2004;279:2737–2746.
   PubMed Web of Science ®Google Scholar
• Jo OD, Martin J, Bernath A, et al. Heterogeneous nuclear ribonucleoprotein A1 regulates cyclin D1 and c-myc internal ribosome entry site function through Akt signaling. J Biol Chem. 2008;283:23274–23287.
   PubMed Web of Science ®Google Scholar
• Silke J, Vucic D. IAP family of cell death and signaling regulators. Methods Enzymol. 2014;545:35–65.
   PubMed Web of Science ®Google Scholar
• Dubrez-Daloz L, Dupoux A, Cartier J. IAPs: more than just inhibitors of apoptosis proteins. Cell Cycle. 2008;7:1036–1046.
   PubMed Web of Science ®Google Scholar
• Holcik M, Lefebvre C, Yeh C, et al. A new internal-ribosome-entry-site motif potentiates XIAP-mediated cytoprotection. Nat Cell Biol. 1999;1:190–192.
   PubMed Web of Science ®Google Scholar
• Van Eden ME, Byrd MP, Sherrill KW, et al. Translation of cellular inhibitor of apoptosis protein 1 (c-IAP1) mRNA is IRES mediated and regulated during cell stress. RNA. 2004;10:469–481.
   PubMed Web of Science ®Google Scholar
• Baranick BT, Lemp NA, Nagashima J, et al. Splicing mediates the activity of four putative cellular internal ribosome entry sites. Proc Natl Acad Sci U S A. 2008;105:4733–4738.
   PubMed Web of Science ®Google Scholar
• Riley A, Jordan LE, Holcik M. Distinct 5ʹ UTRs regulate XIAP expression under normal growth conditions and during cellular stress. Nucleic Acids Res. 2010;38:4665–4674.
   PubMed Web of Science ®Google Scholar
• Aird KM, Ghanayem RB, Peplinski S, et al. X-linked inhibitor of apoptosis protein inhibits apoptosis in inflammatory breast cancer cells with acquired resistance to an ErbB1/2 tyrosine kinase inhibitor. Mol Cancer Ther. 2010;9:1432–1442.
   PubMed Web of Science ®Google Scholar
• Krepela E, Dankova P, Moravcikova E, et al. Increased expression of inhibitor of apoptosis proteins, survivin and XIAP, in non-small cell lung carcinoma. Int J Onc. 2009;35:1449–1462.
   PubMed Web of Science ®Google Scholar
• Zuker M. Mfold web server for nucleic acid folding and hybridization prediction. Nucleic Acids Res. 2003;31:3406–3415.
   PubMed Web of Science ®Google Scholar
• Macejak DG, Sarnow P. Internal initiation of translation mediated by the 5ʹ leader of a cellular mRNA. Nature. 1991;353:90–94.
   PubMed Web of Science ®Google Scholar
• Roller C, Maddalo D. The molecular chaperone GRP78/BiP in the development of chemoresistance: mechanism and possible treatment. Front Pharmacol. 2013;4:10.
   PubMed Web of Science ®Google Scholar
• Casas C. GRP78 at the centre of the stage in cancer and neuroprotection. Front Neurosci. 2017;11:177.
   PubMed Web of Science ®Google Scholar
• Kim YK, Back SH, Rho J, et al. La autoantigen enhances translation of BiP mRNA. Nucleic Acids Res. 2001;29:5009–5016.
   PubMed Web of Science ®Google Scholar
• Le SY, Maizel JV Jr. A common RNA structural motif involved in the internal initiation of translation of cellular mRNAs. Nucleic Acids Res. 1997;25:362–369.
   PubMed Web of Science ®Google Scholar
• Yoon A, Peng G, Brandenburger Y, et al. Impaired control of IRES-mediated translation in X-linked dyskeratosis congenita. Science. 2006;312:902–906.
   PubMed Web of Science ®Google Scholar
• Coldwell MJ, deSchoolmeester ML, Fraser GA, et al. The p36 isoform of BAG-1 is translated by internal ribosome entry following heat shock. Oncogene. 2001;20:4095–4100.
   PubMed Web of Science ®Google Scholar
• Cobbold LC, Spriggs KA, Haines SJ, et al. Identification of internal ribosome entry segment (IRES)-trans-acting factors for the Myc family of IRESs. Mol Cell Biol. 2008;28:40–49.
   PubMed Web of Science ®Google Scholar
• Badura M, Braunstein S, Zavadil J, et al. DNA damage and eIF4G1 in breast cancer cells reprogram translation for survival and DNA repair mRNAs. Proc Natl Acad Sci U S A. 2012;109:18767–18772.
   PubMed Web of Science ®Google Scholar
• Keene JD. RNA regulons: coordination of post-transcriptional events. Nat Rev Genet. 2007;8:533–543.
   PubMed Web of Science ®Google Scholar
• Bisogno LS, Keene JD. RNA regulons in cancer and inflammation. Curr Opin Genet Dev. 2018;48:97–103.
   PubMed Web of Science ®Google Scholar
• Bartel F, Harris LC, Wurl P, et al. MDM2 and its splice variant messenger RNAs: expression in tumors and down-regulation using antisense oligonucleotides. Mol Cancer Res. 2004;2(1):29–35.
   PubMed Web of Science ®Google Scholar
• Brooks CL, Gu W. p53 ubiquitination: mdm2 and beyond. Mol Cell. 2006;21:307–315.
   PubMed Web of Science ®Google Scholar
• Landers JE, Cassel SL, George DL. Translational enhancement of mdm2 oncogene expression in human tumor cells containing a stabilized wild-type p53 protein. Cancer Res. 1997;57:3562–3568.
   PubMed Web of Science ®Google Scholar
• Landers JE, Haines DS, Strauss JF 3rd, et al. Enhanced translation: a novel mechanism of mdm2 oncogene overexpression identified in human tumor cells. Oncogene. 1994;9(9):2745–2750.
   PubMed Web of Science ®Google Scholar
• Capoulade C, Bressac-de Paillerets B, Lefrere I, et al. Overexpression of MDM2, due to enhanced translation, results in inactivation of wild-type p53 in Burkitt’s lymphoma cells. Oncogene. 1998;16:1603–1610.
   PubMed Web of Science ®Google Scholar
• Brown CY, Mize GJ, Pineda M, et al. Role of two upstream open reading frames in the translational control of oncogene mdm2. Oncogene. 1999;18:5631–5637.
   PubMed Web of Science ®Google Scholar
• Jin X, Turcott E, Englehardt S, et al. The two upstream open reading frames of oncogene mdm2 have different translational regulatory properties. J Biol Chem. 2003;278:25716–25721.
   PubMed Web of Science ®Google Scholar
• Akulich KA, Sinitcyn PG, Makeeva DS, et al. A novel uORF-based regulatory mechanism controls translation of the human MDM2 and eIF2D mRNAs during stress. Biochimie. 2019;157:92–101.
   PubMed Web of Science ®Google Scholar
• D’Agostino VG, Sighel D, Zucal C, et al. Screening approaches for targeting ribonucleoprotein complexes: a new dimension for drug discovery. SLAS Discov. 2019;24:314–331.
   PubMed Web of Science ®Google Scholar
• Roos M, Pradere U, Ngondo RP, et al. A small-molecule inhibitor of Lin28. ACS Chem Biol. 2016;11:2773–2781.
   PubMed Web of Science ®Google Scholar
• Muralidharan R, Mehta M, Ahmed R, et al. HuR-targeted small molecule inhibitor exhibits cytotoxicity towards human lung cancer cells. Sci Rep. 2017;7:9694.
   PubMed Web of Science ®Google Scholar
• Wang Z, Bhattacharya A, Ivanov DN. Identification of small-molecule inhibitors of the HuR/RNA interaction using a fluorescence polarization screening assay followed by NMR validation. PLoS One. 2015;10:e0138780.
   PubMed Web of Science ®Google Scholar
• Heise T, Guidotti LG, Cavanaugh VJ, et al. Hepatitis B virus RNA-binding proteins associated with cytokine-induced clearance of viral RNA from the liver of transgenic mice. J Virol. 1999;73:474–481.
   PubMed Web of Science ®Google Scholar
• Heise T, Guidotti LG, Chisari FV. Characterization of nuclear RNases that cleave hepatitis B virus RNA near the La protein binding site. J Virol. 2001;75:6874–6883.
   PubMed Web of Science ®Google Scholar
• Tang J, Zhang ZH, Huang M, et al. Phosphorylation of human La protein at Ser 366 by casein kinase II contributes to hepatitis B virus replication and expression in vitro. J Viral Hepatitis. 2013;20:24–33.
   PubMed Web of Science ®Google Scholar
• Tang J, Huang ZM, Chen YY, et al. A novel inhibitor of human La protein with anti-HBV activity discovered by structure-based virtual screening and in vitro evaluation. PLoS One. 2012;7:e36363.
   PubMed Web of Science ®Google Scholar
• Izumi RE, Das S, Barat B, et al. A peptide from autoantigen La blocks poliovirus and hepatitis C virus cap-independent translation and reveals a single tyrosine critical for La RNA binding and translation stimulation. J Virol. 2004;78:3763–3776.
   PubMed Web of Science ®Google Scholar
• Sommer G, Fedarovich A, Kota V, et al. Applying a high-throughput fluorescence polarization assay for the discovery of chemical probes blocking La: RNA interactions in vitro and in cells. PLoS One. 2017;12:e0173246.
   PubMed Web of Science ®Google Scholar
• Troster H, Metzger TE, Semsei I, et al. One gene, two transcripts: isolation of an alternative transcript encoding for the autoantigen La/SS-B from a cDNA library of a patient with primary Sjogrens’ syndrome. J Exp Med. 1994;180:2059–2067.
   PubMed Web of Science ®Google Scholar
• Padilla PI, Uhart M, Pacheco-Rodriguez G, et al. Association of guanine nucleotide-exchange protein BIG1 in HepG2 cell nuclei with nucleolin, U3 snoRNA, and fibrillarin. Proc Natl Acad Sci U S A. 2008;105:3357–3361.
   PubMed Web of Science ®Google Scholar
• Fouraux MA, Bouvet P, Verkaart S, et al. Nucleolin associates with a subset of the human Ro ribonucleoprotein complexes. J Mol Biol. 2002;320:475–488.
   PubMed Web of Science ®Google Scholar
• Fouraux MA, Kolkman MJ, Van der Heijden A, et al. The human La (SS-B) autoantigen interacts with DDX15/hPrp43, a putative DEAH-box RNA helicase. RNA. 2002;8:1428–1443.
   PubMed Web of Science ®Google Scholar